GARY ANDERSON: Open Payments
NPI 1780687350 · SANDSTONE, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$161 in 9 payments from 8 companies in 2025. Trend: 2023 $113 · 2024 $149 · 2025 $161
Food & beverage: $161
| Company | Payments | Amount |
|---|---|---|
| Xeris Pharmaceuticals, Inc. | 2 | $40 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $28 |
| Aimmune Therapeutics, Inc. | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $17 |
| Collegium Pharmaceutical, Inc. | 1 | $16 |
| Cepheid | 1 | $15 |
| ABBVIE INC. | 1 | $15 |
| Novo Nordisk Inc | 1 | $14 |
Products named: KEVEYIS, CAPLYTA, ZENPEP, BREZTRI, Belbuca, GeneXpert, VRAYLAR, Wegovy.
Industry payments across MN — which companies pay providers there.
